The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index; 10 of the 29 sources its claims cite were checked for support.
Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―
Open accessAbstract
Our systematic reviews suggest that prehospital administration of aspirin and nitroglycerin by non-physician healthcare professionals is beneficial for patients with suspected ACS, although the certainty of evidence is very low. Further investigation is needed to determine the benefit of the prehospital administration of these agents.
Overview
CoChat Summary
## TL;DR
This systematic review found that prehospital aspirin and nitroglycerin given by non-physician healthcare professionals were associated with lower mortality in observational studies of patients ultimately diagnosed with acute myocardial infarction. However, the certainty of evidence was rated very low for both drugs.
## Key findings
- For prehospital aspirin, 3 observational studies (4,350 patients) found lower 30-day mortality with prehospital vs in-hospital aspirin: 93/2,193 (4.2%) vs 160/2,157 (7.4%); OR 0.59 (95% CI 0.35–0.99).
- In 1 observational study (1,726 patients), prehospital aspirin was also associated with lower 1-year mortality: 102/995 (10.3%) vs 143/731 (19.6%); OR 0.47 (95% CI 0.36–0.62).
- For prehospital nitroglycerin, 1 observational study (1,726 patients) found lower 30-day mortality: 52/1,142 (4.6%) vs 71/584 (12.2%); OR 0.34 (95% CI 0.24–0.50).
- The same nitroglycerin study found lower 1-year mortality: 114/1,142 (10.0%) vs 131/584 (22.4%); OR 0.38 (95% CI 0.29–0.50). No significant differences were found for aspirin in reinfarction, stroke, or major hemorrhage.
## Methods
- Systematic review and meta-analysis conducted for 2 clinical questions: prehospital aspirin and prehospital nitroglycerin for adult patients with suspected ACS, administered by non-physician healthcare professionals.
- PubMed was searched for English-language RCTs and non-randomized studies published before August 14, 2020 for aspirin and before July 15, 2020 for nitroglycerin.
- Results were pooled using a random-effects model; risk of bias was assessed with the Cochrane tool, and certainty of evidence was rated with GRADE.
## Limitations
- The paper states the certainty of evidence was very low for both drugs because of risk of bias, imprecision, and indirectness.
- The review included no RCTs; it relied on 3 observational studies for aspirin and 1 observational study for nitroglycerin.
- The authors note they searched only PubMed and limited inclusion to English-language studies, which may have missed relevant evidence.
- Evident from the text: all included studies were in patients ultimately diagnosed with AMI, not the broader population of suspected ACS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
7 Valid · 1 Not valid · 11 Not checked · 14 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Prehospital aspirin administration was associated with significantly lower 30-day and 1-year mortality compared with aspirin administration after arrival at hospital, with odds ratios (OR) of 0.59 (95% confidence interval [CI] 0.35–0.99) and 0.47 (95% CI 0.36–0.62), respectively.”
- Also stated in: § CQ1: Aspirin · plain
“The prehospital administration group had significantly lower 30-day and 1-year mortality than the control group (OR 0.59 [95% CI: 0.35–0.99; P<0.01] and 0.47 [95% CI: 0.36–0.62; P<0.01], respectively).”
§ Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ― > Abstract
What the sources say
- Disputedcites [15] 15. Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002; 39: 1733–1737. sourceExperimental — accuracy not yet measured
Our copy of Zijlstra et al. 2002 reports the opposite for 30-day mortality: Results (Clinical outcome) give 26/860 (3.0%) deaths in the prehospital group versus 24/842 (2.9%) in the in-hospital group, and the Discussion states explicitly 'We did not find a significant difference in mortality between the prehospital and the in-hospital group.' The only odds/relative-risk figures with 95% CIs in the paper are angiographic (TIMI 2–3 flow 31% vs 20%, RR 0.65, CI 0.55–0.78; TIMI 3 flow RR 0.60, CI 0.47–0.78), not the claimed OR 0.59 (0.35–0.99); the lower 30-day mortality of 1.6% vs 3.4% (p = 0.04) is by initial TIMI flow, not by treatment allocation. The study also collected only 30-day/in-hospital clinical outcome (Methods, Data collection), so no 1-year mortality OR of 0.47 (0.36–0.62) exists here, and the comparator was in-hospital aspirin plus heparin rather than 'no prehospital aspirin'. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [16] 16. Barbash I, Freimark D, Gottlieb S, Hod H, Hasin Y, Battler A, et al. Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration. Cardiology 2002; 98: 141–147. source
- Partly supportedcites [17] 17. Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, et al. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction. Scand J Trauma Resusc Emerg Med 2015; 23: 105, doi:10.1186/s13049-015-0188-x. sourceExperimental — accuracy not yet measured
The Results section reports lower one-year mortality among patients given prehospital aspirin than among those not given it (10.1% versus 18.6%; p = 0.009). Our copy does not report the claimed 30-day odds ratio of 0.59 (95% CI 0.35–0.99), nor does that result compare prehospital aspirin with aspirin given after hospital arrival. The Abstract’s Results also state that, after adjustment, only nitroglycerin was associated with reduced one-year mortality. (LLM, conf=0.88)
plainstates an associationn = 4,350- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § CQ1: Aspirin · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Prehospital nitroglycerin administration was also associated with significantly lower 30-day and 1-year mortality compared with no prehospital administration (OR 0.34 [95% CI 0.24–0.50] and 0.38 [95% CI 0.29–0.50], respectively).”
- Also stated in: § CQ2: Nitroglycerin · plain
“The prehospital administration group had significantly lower 30-day and 1-year mortality than the control group (OR 0.34 [95% CI: 0.24–0.50; P<0.01] and 0.38 [95% CI: 0.29–0.50; P<0.01], respectively).”
§ Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ― > Abstract
What the sources say
- Partly supportedcites [17] 17. Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, et al. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction. Scand J Trauma Resusc Emerg Med 2015; 23: 105, doi:10.1186/s13049-015-0188-x. sourceExperimental — accuracy not yet measured
The Discussion (‘Predictors of death’) reports that prehospital nitrate use was associated with a reduced risk of death after adjustment for confounders. But the reported one-year estimate is a hazard ratio of 0.40 (95% CI 0.23–0.70) among patients not on chronic aspirin, not the claimed odds ratio of 0.38 (95% CI 0.29–0.50). The retrieved passages do not report the cited 30-day estimate. (LLM, conf=0.90)
plainstates an associationn = 1,726- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § CQ2: Nitroglycerin · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Prehospital aspirin administration was associated with significantly lower 30-day and 1-year mortality compared with aspirin administration after arrival at hospital, with odds ratios (OR) of 0.59 (95% confidence interval [CI] 0.35–0.99) and 0.47 (95% CI 0.36–0.62), respectively.”
- Also stated in: § CQ1: Aspirin · plain
“The prehospital administration group had significantly lower 30-day and 1-year mortality than the control group (OR 0.59 [95% CI: 0.35–0.99; P<0.01] and 0.47 [95% CI: 0.36–0.62; P<0.01], respectively).”
§ Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ― > Abstract
What the sources say
- Partly supportedcites [17] 17. Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, et al. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction. Scand J Trauma Resusc Emerg Med 2015; 23: 105, doi:10.1186/s13049-015-0188-x. sourceExperimental — accuracy not yet measured
The Results section reports lower one-year mortality among patients given prehospital aspirin than among those not given it (10.1% versus 18.6%; p = 0.009). It does not report the claimed odds ratio of 0.47, a comparison specifically with aspirin given after hospital arrival, or the cited 30-day result. The Results also state that, after adjustment for confounders, only nitroglycerin was associated with reduced one-year mortality. (LLM, conf=0.88)
plainstates an associationn = 1,726- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § CQ1: Aspirin · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For the critical outcome of reinfarction and stroke, and for the important outcome of major hemorrhage, there were no significant differences between the prehospital administration and control groups.”
§ Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ― > Results > CQ1: Aspirin
What the sources say
- Partly supportedcites [15] 15. Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002; 39: 1733–1737. sourceExperimental — accuracy not yet measured
The Results 'Clinical outcome' passage reports the stroke events (one in the prehospital group, 0.1%, vs three in-hospital, 0.4%; four strokes overall, 0.2%), together with bleeding requiring transfusion 5% vs 7% and death/nonfatal reinfarction 4% vs 3.8%, so the substance of 'no significant difference' is consistent with what the paper found — although it gives raw counts and refers to Table 3 rather than stating a significance test for stroke, reinfarction or hemorrhage. The part the source does not support is the attribution to 'prehospital aspirin administration' alone: both arms received aspirin AND heparin, and the Discussion ('Aspirin and other pharmacologic interventions') states explicitly that 'the relative importance of these two components is unknown'. The comparison was also non-randomized, allocated by patient routing (Study limitations), which the citing sentence does not carry. (LLM, conf=0.72)
plainn = 860- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Prehospital nitroglycerin administration was also associated with significantly lower 30-day and 1-year mortality compared with no prehospital administration (OR 0.34 [95% CI 0.24–0.50] and 0.38 [95% CI 0.29–0.50], respectively).”
- Also stated in: § CQ2: Nitroglycerin · plain
“The prehospital administration group had significantly lower 30-day and 1-year mortality than the control group (OR 0.34 [95% CI: 0.24–0.50; P<0.01] and 0.38 [95% CI: 0.29–0.50; P<0.01], respectively).”
§ Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ― > Abstract
What the sources say
- Partly supportedcites [17] 17. Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, et al. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction. Scand J Trauma Resusc Emerg Med 2015; 23: 105, doi:10.1186/s13049-015-0188-x. sourceExperimental — accuracy not yet measured
The Discussion (Predictors of death; page not provided) reports that prehospital nitrate use was associated with a reduced risk of death after adjustment for confounders. The cited paper does not report the claimed 30-day mortality OR of 0.34 (95% CI 0.24–0.50); its Abstract (Results; page not provided) instead reports a one-year hazard ratio of 0.40 (95% CI 0.23–0.70) among patients not on chronic aspirin. (LLM, conf=0.88)
plainstates an associationn = 1,726- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § CQ2: Nitroglycerin · plain
13 more claims
Create a free account to see all 33 claims and to verify the 4 references still open.
- It may state two separate claims as one. 6
- Probably not a substantial claim. 11
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728 · cited 1×
“The critical outcomes of the CQ1 study were: (1) mortality; (2) intracranial bleeding; (3) reinfarction; (4) revascularization; and (5) stroke.”
BackgroundGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Assessing heterogeneity in meta-analysis: Q statistic or I² index?
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Research works printed but not linked: 2
- 8. Japan Resuscitation Council Guidelines 2010. Chapter 5, Acute coronary syndrome, Herusu Shuppan, 2011.
- 9. Japan Resuscitation Council Guidelines 2015. Chapter 5, Acute coronary syndrome, Igaku-Shoin, 2016.
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Kikuchi, M., Tahara, Y., Yamaguchi, J., Nakashima, T., Nomura, O., Tanaka, A., Kojima, S., Hashiba, K., Nakayama, N., Hanada, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0096 · Cited by 29
Self-citationSaito, Y., Tateishi, K., & Kobayashi, Y. (2024) · Circulation Reports · doi:10.1253/circrep.cr-24-0141 · Cited by 27
“99 In the hospitalization setting, team-based management in experienced centers has been shown to improve outcomes in high-mortality conditions such as trauma, sepsis, stroke, and cardiac arrest.”
Géhin, M., Storey, R. F., Bernaud, C., & Dingemanse, J. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2266384 · Cited by 13
“The use of an automatic external defibrillator or aspirin self-medication before emergency medical help arrives can improve survival rates in patients with cardiac arrest or reduce the risk of complications in patients with suspected AMI [55,56].”
Background
Metadata
- Authors
- Nakayama, N., Yamamoto, T., Kikuchi, M., Hanada, H., Mano, T., Nakashima, T., Hashiba, K., Tanaka, A., Matsuo, K., Nomura, O., Kojima, S., Yamaguchi, J., Matoba, T., Tahara, Y., Nonogi, H., & for the Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee
- Affiliations
- Kanagawa Cardiovascular and Respiratory Center (JP)
- Nippon Medical School Hospital (JP)
- Dokkyo University (JP)
- Hirosaki University (JP)
- Kansai Rosai Hospital (JP)
- University of Michigan (US)
- Saiseikai Yokohama-shi Nanbu Hospital (JP)
- Nagoya University (JP)
- Fukuoka University (JP)
- Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital
- Tokyo Women's Medical University (JP)
- Kyushu University (JP)
- National Cerebral and Cardiovascular Center (JP)
- Osaka Aoyama University (JP)
- Corresponding author
- Kikuchi, Migaku
- ORCID
- Venue
- Circulation Reports
- Publisher
- Japanese Circulation Society
- Published
- 2022-10-07
- Volume
- 4
- Issue
- 10
- Pages
- 449-457
- ISSN
- 2434-0790 (ISSN-L)
- PMC
- PMC9535127
- OpenAlex
- W4288057980
- Semantic Scholar
- 440d967bde9d0d65a1fde806e70a7821868188de
- Cited by
- 18
- References
- 23
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 2
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Circulation Reports (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Japanese Circulation Society
- Sahlgrenska Universitetssjukhuset
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- aspirin, nitroglycerin, acute coronary syndrome, prehospital care, emergency medical services, chest pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―. https://app.cochat.ai/papers/10.1253/circrep.cr-22-0060
- The paper
- Nakayama, N., Yamamoto, T., Kikuchi, M., Hanada, H., Mano, T., Nakashima, T., Hashiba, K., Tanaka, A., Matsuo, K., Nomura, O., Kojima, S., Yamaguchi, J., Matoba, T., Tahara, Y., Nonogi, H., & for the Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee. (2022). Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―. Circulation Reports. https://doi.org/10.1253/circrep.cr-22-0060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.